X-Ceptor Therapeutics

X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors.

X-Ceptor Therapeutics, Inc. was acquired by Exelixis, Inc. X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors. The company offers drug discovery platform for the nuclear receptor gene family; and drug candidates to treat cardiovascular and metabolic disorders.